1210 related articles for article (PubMed ID: 19713601)
21. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study.
Kang HJ; Kim JH; Lee SM; Yang HK; Ahn SJ; Han JK
Abdom Radiol (NY); 2018 Dec; 43(12):3279-3287. PubMed ID: 29671007
[TBL] [Abstract][Full Text] [Related]
22. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
23. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
[TBL] [Abstract][Full Text] [Related]
24. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT.
Li R; Guo Y; Hua X; He Y; Ding J; Guo A; Luo M
J Clin Ultrasound; 2007; 35(3):109-17. PubMed ID: 17295272
[TBL] [Abstract][Full Text] [Related]
25. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
28. Characterization by biopsy or CEUS of liver lesions guided by image fusion between ultrasonography and CT, PET/CT or MRI.
Ewertsen C; Henriksen BM; Torp-Pedersen S; Bachmann Nielsen M
Ultraschall Med; 2011 Apr; 32(2):191-7. PubMed ID: 21225564
[TBL] [Abstract][Full Text] [Related]
29. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
[TBL] [Abstract][Full Text] [Related]
30. Modified contrast-enhanced ultrasonography with the new high-resolution examination technique of high frame rate contrast-enhanced ultrasound (HiFR-CEUS) for characterization of liver lesions: First results.
Jung EM; Moran VO; Engel M; Krüger-Genge A; Stroszczynski C; Jung F
Clin Hemorheol Microcirc; 2023; 83(1):31-46. PubMed ID: 35466932
[TBL] [Abstract][Full Text] [Related]
31. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography.
Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK
Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional contrast-enhanced ultrasound of the liver: experience of 92 cases.
Xu HX; Lu MD; Xie XH; Xie XY; Xu ZF; Chen LD; Liu GJ; Liang JY; Lin MX; Wang Z; Huang B
Ultrasonics; 2009 Mar; 49(3):377-85. PubMed ID: 19041996
[TBL] [Abstract][Full Text] [Related]
34. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound.
Ju JX; Zeng QJ; Xu EJ; He XQ; Tan L; Huang QN; Li K; Zheng RQ
Int J Hyperthermia; 2019; 36(1):785-793. PubMed ID: 31431086
[No Abstract] [Full Text] [Related]
35. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors.
Xu E; Long Y; Li K; Zeng Q; Tan L; Luo L; Huang Q; Zheng R
Int J Hyperthermia; 2019 Jan; 35(1):159-167. PubMed ID: 30300032
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies.
Pschierer K; Grothues D; Rennert J; da Silva NP; Schreyer AG; Melter M; Stroszczysnski C; Jung EM
Clin Hemorheol Microcirc; 2015; 61(2):333-45. PubMed ID: 26444615
[TBL] [Abstract][Full Text] [Related]
39. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
Wang Y; Jing X; Ding J
Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
[TBL] [Abstract][Full Text] [Related]
40. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
